Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Chubb
Cantor Fitzgerald
Mallinckrodt
Citi
Moodys

Generated: July 21, 2019

DrugPatentWatch Database Preview

Patent: 5,886,145

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,886,145
Title: Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
Abstract:New tumor rejection antigen precursors, and the nucleic acid molecules which code for them, are disclosed. These tumor rejection antigen precursors are referred to as NAG tumor rejection antigen precursors, and the nucleic acid molecules which code for them are referred to as NAG coding molecules. Various diagnostic and therapeutic uses of the coding sequences and the tumor rejection antigen precursor molecules are described.
Inventor(s): Guilloux; Yannick (Nantes, Cedex, FR), Jotereau; Francine (Nantes, Cedex, FR), Boon-Falleur; Thierry (Brussels, BE), Lucas; Sophie (Brussels, BE), Brichard; Vincent (Brussels, BE)
Assignee: INSERM (Institute National de la Sante et de la Rechereche Medicale) (Paris, FR)
Application Number:08/915,972
Patent Claims:see list of patent claims

Details for Patent 5,886,145

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up INSERM (Institute National de la Sante et de la Rechereche Medicale) (Paris, FR) ➤ Sign Up RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up INSERM (Institute National de la Sante et de la Rechereche Medicale) (Paris, FR) ➤ Sign Up RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up INSERM (Institute National de la Sante et de la Rechereche Medicale) (Paris, FR) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Healthtrust
Express Scripts
Cipla
Julphar
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.